Pro Dip

Quick links to important sections

Pro Dip

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pro Dip

What is Pro Dip?

Pro Dip is a specialized topical solution used in the field of dermatology and wound care. It is formulated as a protective coating or a therapeutic soak, depending on the specific clinical application. The primary purpose of the solution is to create a controlled environment for affected skin areas, often utilized to manage irritation, promote moisture retention, or deliver localized treatment to the epidermal layers.

Composition and Mechanism

The preparation typically consists of a combination of active ingredients and a liquid base designed for optimal skin penetration. When applied, Pro Dip works by interacting with the skin's surface to provide a barrier against external contaminants. This barrier function is essential for supporting the natural recovery process of the skin, particularly in cases where the cutaneous integrity has been compromised.

Clinical Applications

Pro Dip is frequently employed in professional healthcare settings for several specific purposes:

  • Skin Conditioning: It helps in softening hyperkeratotic tissue, making it easier to manage thickened or scaly skin patches.
  • Hydration Support: The solution assists in maintaining the hydration levels of the stratum corneum, which is the outermost layer of the skin.
  • Pre-procedural Preparation: In certain dermatological workflows, it is used to prepare the skin surface before further interventions or examinations.

Therapeutic Role

Unlike standard moisturizers, Pro Dip is categorized as a therapeutic aid. It is designed to address more significant skin concerns that require a structured approach to topical management. By providing a consistent application method, it ensures that the affected areas receive uniform exposure to its constituent properties, facilitating a stable environment for skin maintenance.

Regulatory References

  1. WHO JECFA data on Cypermethrin

What side effects are possible with Pro Dip?

Possible side effects and safety information

Pro Dip contains the active substance Cypermethrin, a synthetic pyrethroid whose safety profile is defined by its known toxicological properties and constraints documented in official regulatory sources. The adverse reactions are primarily described in the context of overexposure or systemic toxicity rather than routine frequency-based reports.

Signs of adverse effects following systemic exposure are classified under specific System-Organ Classes (SOC):

  • Nervous System Disorders: Includes signs such as tremors, incoordination, salivation, and writhing, consistent with the active substance's neurotoxic action.
  • Skin and Subcutaneous Tissue Disorders: Localized effects may involve a tingling sensation, pruritus (itching), and skin reddening in the area of application.
  • Gastrointestinal Disorders: Effects following accidental ingestion can include nausea, vomiting, and abdominal pain.

In cases of significant overexposure, the official safety profile documents serious adverse reactions. These high-tier risks include prolonged convulsions, respiratory depression, and coma, emphasizing the rapid and acute nature of the toxicity syndrome.

Regulatory documents also establish essential safety constraints for the product's use. The official label explicitly prohibits use in certain non-target domestic animals, such as cats, due to known species-specific sensitivities. Furthermore, regulatory mandates require strict caution to avoid environmental release, as the substance is classified as highly toxic to aquatic life, including fish and invertebrates. The onset of neurotoxic signs is noted to be rapid following systemic absorption.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Pro Dip (Cypermethrin) is associated with documented neurological effects, often referred to as the CS syndrome in regulatory toxicology. Any evidence of systemic exposure requires immediate attention as mandated by official health authorities.


Documented Manifestations and Severe Outcomes

Overdose symptoms primarily involve the Central Nervous System (CNS) and may include coarse whole body tremors, profuse salivation, and choreoathetosis (sinuous writhing). Localized topical exposure is documented to cause temporary paresthesia (tingling or burning) and itching confined to the site of contact. In cases of substantial systemic exposure, regulatory reports indicate a risk of escalation to severe, life-threatening manifestations, including generalized seizures, coma, and acute respiratory failure.


Required Emergency Actions and Management

Immediate medical help must be sought from a physician or a poison control center if any signs of systemic toxicity are observed. This action is critical given the documented potential for escalation. Upon contamination, the official guidance is to immediately remove soiled clothing and thoroughly wash the skin. Treatment is officially defined as symptomatic and supportive, as regulatory documents state that no specific antidote is known for Cypermethrin poisoning. Hospitalization and continuous monitoring are typically required for patients presenting with systemic toxicity to manage potential complications.

Therapeutic Uses of Pro Dip

What Pro Dip Treats: Main Uses and Benefits

The therapeutic application of Pro Dip is primarily used for the management of external parasites in livestock, providing symptomatic relief and protective health benefits primarily for cattle and sheep. The active ingredient is commonly applied topically for the control of a range of ectoparasites.

Control of Major External Parasites

The preparation is commonly used across conditions defined by the presence of significant parasitic infestations, including the management of ticks, biting and sucking lice, and the sheep scab mite (Psoroptes ovis). The primary benefit provides support that helps ease the animal's overall symptom burden and may assist with limiting the spread across the herd or flock.

Symptomatic Relief of Skin Irritation

Quick Fact: Relief for Irritation

The treatment is generally applied when animals display symptoms related to physical discomfort and pruritus (itching) caused by parasites, which often leads to compulsive scratching and subsequent hair or wool loss. The resulting symptomatic relief contributes to improved comfort and assists with maintaining skin integrity.

Pro Dip is commonly utilized in clinical settings to provide support during periods of high risk for infestation, notably in situations relevant for easing the risk of blowfly strike in sheep. Furthermore, its use generally assists with the management of nuisance and biting flies and supports the reduction of tick-borne disease vector populations.

Eligibility and Restrictions for Use

Who Can and Cannot Use Pro Dip? (Official Eligibility Rules)

Official regulatory documents define strict population eligibility for Pro Dip (Cypermethrin) based on species, age, and physiological status.


Eligibility Scope

Category Regulatory Status
Approved Target Species Use is allowed only in Cattle and Sheep (Bovine and Ovine species).
Absolute Contraindications Contraindicated in animals with known hypersensitivity to Cypermethrin or any component.
Minimum Age Restriction Prohibited for use in Lambs less than one week old.
Time-Sensitive Prohibition Prohibited for use in Cattle within four weeks before parturition (calving).

Population-Specific Restrictions

Certain populations require restricted use or caution as documented in official labeling. The treatment is not recommended for livestock that are sick, stressed, or convalescent. Furthermore, a minimum bodyweight threshold applies for specific uses, as the product must not be administered to sheep less than 12.5 kg for blowfly strike prevention. While use is permitted in pregnant and lactating cattle and sheep, special care is required when handling pregnant ewes during application. These restrictions, classifications, and prohibitions are derived directly from regulatory documents such as the EMA and UK VMD.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Pro Dip (Cypermethrin) around specific chemical prohibitions and documented pharmacokinetic interference. This section describes official constraints and known substance interactions.


Documented Interaction Patterns

Category Regulatory Statement
Formal Prohibitions Co-administration or co-use with soaps or other chemicals is formally restricted and prohibited at the time of application.
Metabolic Clearance Co-exposure to substances like Piperonyl Butoxide and Organophosphate compounds can increase Cypermethrin exposure. These agents inhibit key enzymes (e.g., CYP450, carboxylesterases) required for the active substance’s metabolic clearance, leading to a risk of reduced elimination.
Pharmacodynamic Risk Cypermethrin is documented to potentiate the effects of centrally acting drugs, such as certain CNS depressants (e.g., Pentobarbital), indicating a risk of additive neurotoxic effects.
Population-Specific Caution A metabolic caution exists for species with a known UGT1A6 enzyme deficiency (e.g., felines). This genetic variation limits the body's ability to clear the substance, increasing the relevance of exposure-modifying interactions.

Official Summary of Interaction Structure

The product's regulatory profile defines clear restrictions on co-use with topical agents and highlights specific metabolic interactions that officially increase systemic exposure by reducing clearance. This interaction structure focuses on maintaining a safe exposure margin by restricting co-administration with neurotoxic agents or enzyme inhibitors.

Mechanism of Action

Pro Dip modulates the WNT/beta-catenin pathway, influencing the expression of osteoprotegerin (OPG) and the Receptor Activator of NF-kappaB Ligand (RANKL) ratio. The drug acts as an inhibitor on the G-protein coupled receptor 1 (GPCR1) cascade, thereby inhibiting the downstream signaling mediated by the osteoclast differentiation factor. This specific molecular interaction affects the receptor-ligand binding affinity, leading to a shift in the cellular balance toward a decrease in osteoclastogenesis. The dual action involves influencing the dynamics of both the RANK-L and OPG signaling axes, and the overall pharmacodynamic mechanism includes a specific blockade of the p38 MAPK pathway. The consequence is a tissue-level modulation resulting in reduced bone resorption.

Dosage and Administration Information

How to Use Pro Dip: Official Administration Guidelines

Pro Dip (Cypermethrin) administration involves specific protocols detailing the route, dilution requirements, and application schedule. The product is for Topical Application to livestock, utilizing methods such as a Plunge Dip or Spray Race.


Official Usage Instructions

Instruction Category Administration Guideline
Route of Administration Topical Application only.
Standard Dilution The ready-to-use application wash must be prepared at a charge dilution of 1 part concentrate to 1000 parts water (1:1000 ratio).
Concentrate Preparation The concentrate requires mandatory dilution and proper pre-mixing with water to form a stable emulsion or suspension before it is added to the full volume of the wash.
Routine Frequency Treatment for routine control is typically scheduled for application at fortnightly intervals, with more frequent use required for acute infestations.
Specific Schedule Management of certain conditions, such as sheep scab, requires a specific two-dipping cycle separated by a mandatory nine-day interval.

Time-Based Constraints

Specific time constraints apply to application and harvest. A critical seven-day minimum Withdrawal Period must be observed between the final application of the medicine and the time the treated animal is cleared for slaughter for human consumption. Furthermore, the administration procedure includes a rule that calves under three months of age must be administered to separately from the main herd.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Pro Dip (Cypermethrin)

This section provides a summary of the official research structure and types of evidence that have been used to evaluate Pro Dip, focusing only on what the studies explored and reported, without offering any clinical advice or interpretation of individual outcomes.

Evidence for the Control of Tick Infestations

Research exploring the activity of Pro Dip on ticks includes both controlled field trials (in vivo studies) conducted on cattle and sheep, and laboratory bioassays (in vitro studies) that test the parasite's susceptibility. The primary outcomes measured in these investigations included the percentage of tick mortality (kill rate) and the subsequent reduction in live tick counts observed on the host animals. Studies reported measurements of parasite mortality and reductions in parasite numbers in the observed populations. Research explored whether the rapid activity observed in the laboratory is associated with patterns of rapid reduction in field conditions.

Evidence for the Management of Lice and Mite Infestations

The evidence base for managing lice and mites, including the sheep scab mite (Psoroptes ovis), comes primarily from controlled field efficacy trials. Research examined the compound's activity in animals with active infestations. The studies focused on outcomes related to parasite count reduction or elimination, as well as the tracking of physical signs. This included monitoring outcomes related to physical discomfort such as pruritus (itching) and the healing of associated skin lesions. Studies reported patterns of change in symptoms related to physical discomfort and pruritus following the application protocols.

Study Durability and Long-Term Follow-up

Research has primarily explored short- to intermediate-term symptom changes following application. The follow-up durations in key efficacy trials typically extend up to 4 to 6 weeks, which characterizes the residual activity period described in regulatory summaries. Evidence for long-term outcomes, such as sustained low-level infestation across multiple seasons, is limited. Comparative evidence that tracks the long-term maintenance of a parasite-free status against other compound classes is not fully established and remains an area for further investigation.

What Remains Uncertain in the Research Record

The most significant research limitation consistently reported in scientific literature is the emergence of pyrethroid resistance in various tick and insect populations globally. This means that results apply only to the populations studied at the time, and field performance may be influenced by local resistance patterns. Additionally, comparative evidence is lacking for certain groups, as not all studies directly compared all commercial formulations (e.g., dip versus spray) under identical conditions.

Key Studies & References

  1. Control of Sheep Scab and other Ectoparasites of Sheep - SRUC (Guidance Document, relevant for long-term and comparative evidence gaps)

Frequently Asked Questions (FAQ)

Common questions about Pro Dip (FAQ)


Q: How quickly can I expect Pro Dip to start working?

Regulatory information describes the active substance, Cypermethrin, as a potent, fast-acting neurotoxin in the target pests. While official documentation does not typically provide a specific time range for the expected therapeutic outcome on the host animals, the mechanism of action is characterized by a rapid effect on the parasite's nervous system.


Q: Does Pro Dip have different names in other countries?

Official regulatory bodies internationally recognize the active ingredient by its non-proprietary name, Cypermethrin (INN). The brand name 'Pro Dip' is specific to a regional registration, but the compound's core identity is standardized in official international classifications like those used by the EMA and FDA.


Q: Can Pro Dip be taken by older adults?

According to official documentation, Pro Dip is designated as a veterinary preparation and is approved for use only in Cattle and Sheep. The regulatory profile for this product does not address or include information regarding its use in humans, including older adults.


Q: Are there any common over-the-counter supplements that interact with Pro Dip?

Official regulatory documents specifically mention that Cypermethrin's metabolic clearance (how the body breaks it down) can be reduced by certain enzyme inhibitors, and that the substance is documented to potentiate the effects of certain centrally acting drugs. Official information does not typically provide a comprehensive assessment of every common over-the-counter supplement.


Q: Is it true that Pro Dip can cause weight changes?

Official toxicology databases and animal studies have noted that changes in body weight were observed in research involving Cypermethrin, along with other physical signs documented in those studies.


Q: Does Pro Dip affect your ability to drive or operate machinery?

Pro Dip is regulated as a veterinary medicine, and its label does not provide warnings for human activities like driving. However, the official safety information for the active substance, Cypermethrin, documents overexposure signs in the human Nervous System, such as tremors and incoordination, which are consistent with the safety profile for the human administrator.


Q: Is Pro Dip considered a long-term treatment option?

The research evidence cited in regulatory summaries focuses on short- to intermediate-term symptom changes following application, with follow-up durations typically extending up to four to six weeks. Official documentation indicates that evidence for sustained, multi-season or very long-term outcomes is limited.


Q: What should I do if the side effects of Pro Dip seem unusual?

Official guidelines note that serious or unusual adverse reactions observed should align with official reporting procedures to the relevant regulatory authority (such as the FDA, EMA, or TGA) or the product manufacturer. Regulatory bodies define this mechanism for safety surveillance.


Q: Are there certain foods or drinks I should avoid while taking Pro Dip?

Official safety data sheets for the concentrate define restrictions on consuming food, drink, or smoking while administering the product to prevent accidental human exposure. The product is also restricted from being stored near animal feed or human food to prevent contamination.


Q: Is Pro Dip suitable for use by children or adolescents?

According to official documentation, Pro Dip is designated as a veterinary preparation and is approved for use only in Cattle and Sheep. The regulatory profile for this product does not address or include information regarding its use in humans, including children or adolescents.


Q: Do studies suggest Pro Dip is generally well-tolerated?

The active ingredient is formally classified as a Synthetic Pyrethroid compound whose primary function is the targeted control of pests. The official safety profile focuses on risks associated with overexposure or systemic toxicity and documents adverse reactions in the nervous system, skin, and gastrointestinal systems.


Q: Does Pro Dip stay in your system for a long time after stopping?

Official instructions mandate a seven-day minimum Withdrawal Period between the final application and when the treated animal is cleared for slaughter. Scientific literature further indicates that the elimination half-life (the time it takes for the substance to reduce by half) in mammals typically ranges from 6 to 12 hours.


Q: Is there a generic version of Pro Dip available?

Pro Dip contains the active ingredient Cypermethrin. The availability of generic equivalents or other brand-name products containing the same active substance is determined by individual regulatory bodies based on the market approval and patent status for the formulation in that region.


Q: Are there specific medical conditions that prevent someone from using Pro Dip?

The official label states that the product is contraindicated (prohibited) for use in animals with known hypersensitivity to Cypermethrin or any other component included in the product formulation.


Q: Is there published data on the long-term use of Pro Dip?

Official research summaries state that the evidence base has primarily explored short- to intermediate-term symptom changes following application. Evidence for outcomes such as sustained low-level infestation across multiple seasons is described as limited.


Q: Why do some patients stop taking Pro Dip?

Official research identifies the emergence of pyrethroid resistance in various parasites as a significant limitation that can influence how the treatment performs in the field. Regulatory documents for similar products also note that reasons for discontinuation include lack of efficacy or observed side effects.


Q: Is it common to feel stomach upset when first starting Pro Dip?

Gastrointestinal side effects, such as nausea, vomiting, and abdominal pain, are officially documented in the context of accidental ingestion of the product. The regulatory summary does not describe stomach upset as a common event from routine, correctly administered topical use.


Q: Can Pro Dip affect sleep patterns?

The official safety information documents risks to the Nervous System, which include signs such as tremors and incoordination. Neurological effects are a recognized area of study for this class of substance.


Q: How does the typical duration of Pro Dip's effect compare to other medicines in its class?

The product's residual activity period is defined in regulatory summaries by key efficacy trials, which typically extend up to four to six weeks. Official documentation notes that comparative evidence tracking long-term effectiveness against other compound classes is not fully established.


Q: Are there warnings about combining Pro Dip with alcohol?

Pro Dip is a veterinary medicine and does not carry regulatory warnings for human alcohol consumption. However, the safety data sheet for the concentrate strictly instructs Do not eat, drink or smoke when using this product to prevent accidental ingestion by the human administrator.


Q: Is the purpose of Pro Dip primarily for symptom relief or disease modification?

Pro Dip is officially classified as an ectoparasiticide, meaning its primary function is the control and elimination of external pests (ticks, mites, lice). Regulatory research documents the measurement of parasite count reduction or elimination and the tracking of physical signs such as the healing of associated skin lesions.


Q: How can I tell if Pro Dip is working as intended?

Official research focuses on measurable outcomes, which include the percentage of tick mortality (kill rate), the subsequent reduction in live tick counts on the host animals, and changes in symptoms related to physical discomfort such as pruritus (itching) and the healing of skin lesions.


Q: Does Pro Dip interfere with birth control pills?

Pro Dip is officially designated as a veterinary preparation for use only in Cattle and Sheep. The regulatory profile for this product does not address or include information regarding interactions with human medications, including birth control pills.


Q: Is Pro Dip available without a prescription in any form?

Many products containing Cypermethrin are classified as Restricted Use Pesticides by regulatory bodies, such as the EPA, due to their toxicity profile. This regulatory status often means that purchase and use may be restricted to certified or authorized applicators, which impacts general availability.


Q: Is it possible to develop a tolerance to Pro Dip over time?

Official research records document the significant limitation of the emergence of pyrethroid resistance in various tick and insect populations globally. This indicates that the parasites may become less susceptible to the treatment over time, rather than the host animal developing tolerance to the product.


Q: What official information is available about discontinuing Pro Dip?

Regulatory documents mandate a critical seven-day minimum Withdrawal Period between the final application of the product and when the animal is cleared for slaughter for human consumption. This is the primary time-based constraint related to stopping treatment.


Q: Do studies include a diverse range of patient populations for Pro Dip?

Official eligibility rules limit use to Cattle and Sheep (Bovine and Ovine species), with specific restrictions regarding age (e.g., lambs less than one week old) and weight. Research for regulatory approval includes controlled field trials conducted specifically on these approved target species.

How should Pro Dip be stored and disposed of?

How to Store and Dispose of Pro Dip?

The storage and disposal of Pro Dip (Cypermethrin) are strictly governed by regulatory requirements to ensure product stability and environmental safety.


Official Storage Requirements

Area Requirement
Temperature & Environment Keep cool, dry, and well-ventilated. Must be protected from heat, ignition sources, and freezing.
Container & Security Store in the original container only, kept tightly closed and stored locked up. Keep out of reach of children and animals.
Contamination Must be stored away from food, feed, fertilizers, and strong oxidizing agents.

Official Disposal Instructions

Disposal of both the container and unused product must follow local, regional, and national regulations, typically by routing to an approved waste disposal plant. Release to the environment is strictly prohibited; do not allow the product to enter sewers, surface water, or ground water due to its high aquatic toxicity.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pro Dip found in:

A-Z Index: